Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects

被引:21
|
作者
Akanji, Abayomi O.
Ohaeri, Jude U.
Al-Shammri, Suhail A.
Fatania, Hasmukh R.
机构
[1] Kuwait Univ, Fac Med, Dept Pathol, Clin Chem Unit, Safat 13110, Kuwait
[2] Psychol Med Hosp, Dept Psychiat, Kuwait, Kuwait
[3] Kuwait Univ, Fac Med, Dept Med, Safat, Kuwait
[4] Kuwait Univ, Fac Med, Dept Biochem, Safat, Kuwait
关键词
Arabs; atherogenic dyslipidaemia; insulin-like growth factor-I (IGF-I); IGF-II; insulin-like growth factor-binding protein (IGFBP); schizophrenia;
D O I
10.1515/CCLM.2007.265
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Insulin-like growth factors (IGFs) are believed to be important in brain development and repair following neuronal damage. It is also speculated that IGFs are involved in the association of foetal and pre-adult growth with schizophrenia (SZ). Methods: The aim of this study was to assess levels of IGF-I, IGF-II and IGF binding protein (IGFBP)-3 and their associations in male Arab patients with SZ (n=53) and healthy control subjects (HC; n=52). Anthropometric and demographic data were collected for each subject for whom blood specimens were analysed for serum lipoproteins, apolipoprotein B (apoB), IGF-I, IGF-II and IGFBP-3. Results: The SZ group had lower serum total cholesterol, apoB and uric acid levels than the HC group (p < 0.05). IGF-II levels were significantly higher in the SZ group (p=0.02) and correlated positively with levels of atherogenic lipoproteins - total cholesterol, low-density lipoprotein, apoB - and IGFBP-3. The pattern of correlations between the IGFs and the various parameters differed somewhat between the HC and SZ groups. Conclusions: These results demonstrate that IGF-II levels are increased in patients with SZ and show significant associations with atherogenic lipoproteins. We suggest a possible link between IGF-II metabolism and atherogenesis in SZ.
引用
收藏
页码:1229 / 1231
页数:3
相关论文
共 50 条
  • [31] PARTITION OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING SITES BETWEEN THE IGF-I AND IGF-II RECEPTORS AND IGF-BINDING PROTEINS IN THE HUMAN KIDNEY
    CHIN, E
    MICHELS, K
    BONDY, CA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (01): : 156 - 164
  • [32] A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk
    Allen, NE
    Roddam, AW
    Allen, DS
    Fentiman, IS
    Silva, ID
    Peto, J
    Holly, JMP
    Key, TJ
    BRITISH JOURNAL OF CANCER, 2005, 92 (07) : 1283 - 1287
  • [33] INSULIN-LIKE GROWTH-FACTORS (IGF)-I AND IGF-II AND IGF-BINDING PROTEINS IN THE PROLACTINOMA CYST FLUID
    ZUMKELLER, W
    SAAF, M
    RAHN, T
    ONKOLOGIE, 1994, 17 (06): : 600 - 603
  • [34] Insulin-like growth factor II (IGF-II) inhibits insulin-like growth factor binding protein I (IGFBP-1) production in luteinized human granulosa cells with a potency similar to insulin-like growth factor I (IGF-I) and higher than insulin
    Poretsky, L
    Chun, B
    Liu, HC
    Rosenwaks, Z
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09): : 3412 - 3414
  • [35] CHARACTERIZATION OF THE AFFINITIES OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEINS 1-4 FOR IGF-I, IGF-II, IGF-I/INSULIN HYBRID, AND IGF-I ANALOGS
    OH, Y
    MULLER, HL
    LEE, DY
    FIELDER, PJ
    ROSENFELD, RG
    ENDOCRINOLOGY, 1993, 132 (03) : 1337 - 1344
  • [36] Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer
    Cardillo, MR
    Monti, S
    Di Silverio, F
    Gentile, V
    Sciarra, F
    Toscano, V
    ANTICANCER RESEARCH, 2003, 23 (5A) : 3825 - 3835
  • [37] Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer
    Harman, SM
    Metter, EJ
    Blackman, MR
    Landis, PK
    Carter, HB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11): : 4258 - 4265
  • [38] NO EVIDENCE FOR REDUCED SPONTANEOUS OR GROWTH-HORMONE-STIMULATED SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR (IGF)-I, IGF-II OR IGF BINDING-PROTEIN-3 IN WOMEN WITH SPINAL OSTEOPOROSIS
    KASSEM, M
    BRIXEN, K
    BLUM, W
    MOSEKILDE, L
    ERIKSEN, EF
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (02) : 150 - 155
  • [39] Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures
    Sugimoto, T
    Nishiyama, K
    Kuribayashi, F
    Chihara, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (08) : 1272 - 1279
  • [40] Leptin, insulin-like growth factor (IGF)-I and IGF binding protein-3 levels in children with constitutional delay of growth
    Bideci, A
    Cinaz, P
    Hasanoglu, A
    Tümer, L
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2002, 15 (01): : 41 - 46